Phase I Epigenetic Priming Using Decitabine With Induction Chemotherapy in AML
Clinical trial NCT00538876 · COMPLETED
Trial details
- NCT number
- NCT00538876
- Sponsor
- Weill Medical College of Cornell University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2009-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.